Notícias

A new coronavirus disease named COVID-19, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is rapidly spreading worldwide. However, there...

Anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines elicit lower humoral responses in solid-organ transplant recipients. This is the first...

Divulgação MJSP

A 6ª reunião ordinária do Conselho Nacional de Combate à Pirataria (CNCP), foi realizada em clima de comemoração...

Given the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, we studied...

O Comitê-Executivo de Gestão da Câmara de Comércio Exterior (Gecex/Camex) aprovou na última segunda-feira (29/11) a Resolução Gecex nº 272,...

SARS-CoV-2 is highly homologous to SARS-CoV. To date, the main protease (Mpro) of SARS-CoV-2 is regarded as an important drug...

The coronavirus disease of 2019 (COVID-19) has caused significant morbidity and mortality among infected individuals across the world. High transmissibility...

Empresa completa 28 anos e prevê diversificação e ampliação do portfólio. A ambição da farmacêutica é se tornar num curto...

COVID-19 is a clinical outcome of viral infection emerged due to strain of beta coronavirus which attacks the type-2 pneumocytes...

The novel coronavirus has a high mortality rate (over 1% for patients older than 50). This could be only partially...

Coronavirus disease 2019 (COVID-19) is a rapidly growing pandemic that requires urgent therapeutic intervention. Finding potential anti COVID-19 drugs aside...

New neutralizing agents against SARS-CoV-2 and associated mutant strains are urgently needed for the treatment and prophylaxis of COVID-19. Herein,...